Burjeel Holdings Reports Robust Financial Growth in First Half of 2026 as Demand for Healthcare Surges
Dubai, UAE – In a significant demonstration of resilience and operational excellence, Burjeel Holdings has announced a remarkable financial performance for the first half of 2026. The Abu Dhabi-based healthcare provider reported a striking 97.4% increase in net profit before one-off items, amounting to AED 227 million. This extraordinary growth has been attributed to heightened patient volumes, enhanced operational efficiencies, and the ongoing expansion of its healthcare network.
For the six-month period ending June 30, 2026, Burjeel Holdings’s revenues reached AED 2.79 billion, representing a year-on-year increase of 4.4%. Notably, the organization recorded an impressive 9.9% rise in patient visits, totaling over 3.7 million. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)—excluding one-off items—increased by 24.6% to AED 517 million, underscoring a robust operational performance across the group’s diverse portfolio.
Second-Quarter Performance: A Positive Upswing
Burjeel Holdings reported accelerated momentum during the second quarter of 2026, primarily fueled by the recovery in demand for elective and complex medical procedures. Quarterly revenue increased by 3.7% year-on-year, reaching AED 1.46 billion, while the number of patient visits surged by 12.4%. The net profit before one-off items more than doubled, climbing to AED 171 million, compared to AED 76 million from the same period the previous year. Adjusted EBITDA for the quarter experienced a substantial 35% increase, amounting to AED 316 million.
This upswing is indicative of a broader trend across the healthcare sector as patients resume seeking both routine and specialized medical care, a phenomenon that reflects the region’s growing confidence in healthcare services post-pandemic.
Rising Demand for Specialized Healthcare Services
An analysis of patient demographics and service utilization reveals an increasing demand in specialized healthcare. The group experienced a 10% rise in outpatient visits during the first half, escalating to 12.5% in the second quarter. This surge was driven by increased interest in family medicine, pediatrics, obstetrics and gynecology, as well as fertility treatments and advanced diagnostic services. The inpatient volumes also rose by 7.2%, bolstered by greater activity in oncology, cardiology, and gastroenterology, coupled with the resurgence of high-acuity elective surgeries.
In a notable achievement, Burjeel conducted 24,610 surgeries in the second quarter alone, marking a 7.4% growth compared to the previous year. The healthcare group operates a network of 1,784 beds, with occupancy averaging 69%, and the number of physicians increased to 1,801, reflecting Burjeel’s commitment to expanding its professional expertise to accommodate growing demand.
Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, commented on these favorable results, stating, “The accelerating patient activity during the second quarter has further reinforced our confidence in the structural demand for high-quality, specialized healthcare across the region.”
Enhanced Earnings Across Hospital Divisions
The hospitals division of Burjeel Holdings continued to be a significant driver of growth, contributing 89% of the total group revenue. It recorded AED 2.5 billion in revenue during the first half, up 5.4% year-on-year. Furthermore, adjusted EBITDA from hospitals escalated by 21.1% to AED 562 million, paralleled with an improvement in margins to 22.5%. Burjeel Medical City, in particular, displayed remarkable growth, boasting a second-quarter EBITDA increase of 58.3%, contributing to a peak EBITDA margin of 26.3%, driven by a rise in complex procedures conducted.
On the medical centers front, revenue surged by 8.4% to AED 248 million, while adjusted EBITDA experienced an impressive leap of 56.2%, reaching AED 28 million. This growth trajectory can be largely attributed to the scaling operations of over 15 recently launched facilities.
Financial Robustness and Future Expansion
Burjeel Holdings has also made notable strides in improving its cash flow position. Operating cash flow surged by 76.8% to AED 405 million, while free cash flow increased by 36.4% to AED 354 million. Despite continuing investments in expansion, net leverage remained stable at 1.8x.
In July, Burjeel successfully concluded its inaugural US0 million sukuk issuance under its US.5 billion programme, showcasing a significant oversubscription rate of 3.2 times, with 61% of allocations going to international investors. The proceeds will primarily facilitate the refinancing of existing debt, including repayments of AED 1.6 billion in bank facilities.
During this reporting period, Burjeel also expanded its footprint with new medical centers in Dubai Silicon Oasis and a flagship Tajmeel aesthetics and wellness center in Jumeirah. Additionally, the healthcare group is enhancing its specialized clinical services by advancing oncology and transplant programs, including liver and deceased-donor kidney procedures.
As Burjeel Holdings continues to solidify its position in the healthcare sector, the future outlook remains optimistic, fortified by a commitment to innovation, quality service, and continued expansion in the UAE and beyond.
Tags:
#BusinessNews #HealthNews #UAE #AbuDhabi #Healthcare #BurjeelHoldings #FinancialPerformance